Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert

Seeking Alpha

Aaron F. Barkoff » Articles » MYL |

Aaron F. Barkoff picture

Aaron F. Barkoff

Federal Circuit Affirms Fee Award to Takeda
on Dec 10, 2008 • MYL, TKPHF.PK
Barr and Mylan Invalidate Boehringer Ingelheim's Patent on Mirapex
on Jul 06, 2008 • BRL, MYL
Mylan Prevails Over AstraZeneca in Appeal of Prilosec Case
on Jun 12, 2008 • AZN, IPXL, MYL
Court Affirms Decision Protecting Ortho-McNeil's Topamax Against Mylan's Generic
on Apr 02, 2008 • JNJ, MYL
Court Upholds Validity of AstraZenec's Prilosec Patents
on Jun 05, 2007 • AZN, IPXL, MYL
Pfizer's Petition for Rehearing in Norvasc Case Denied
on May 22, 2007 • MYL, PFE
FDA Decision on Pfizer's Norvasc Exclusivity Upheld
on May 02, 2007 • MYL, PFE, TEVA
Generics Challenge FDA's Decision On Pfizer Drug
on Apr 27, 2007 • MYL, PFE, TEVA
FDA Refuses Approval To Generics Of Pfizer Drug, Except Mylan
on Apr 19, 2007 • MYL, PFE
Pfizer and Mylan Fight to Defend Norvasc Against Generics
on Apr 09, 2007 • MYL, PFE
Mylan Can Breathe Easy on Norvasc Until April 13
on Mar 27, 2007 • MYL
Biotech Legal Battles: Will Other Generics Follow Mylan's Lead?
on Mar 26, 2007 • MYL, PFE
Surprise Ruling: Court Invalidates Pfizer's Blood Pressure Drug Patent
on Mar 23, 2007 • MYL, PFE
Pfizer Successfully Defends Hypertension Drug Again, This Time Against Mylan
on Feb 28, 2007 • MYL, PFE
Court Protects Johnson & Johnson's Topamax from Mylan's Generic
on Feb 15, 2007 • JNJ, MYL

More on MYL by Aaron F. Barkoff

Articles by Ticker

Latest Comments on Aaron F. Barkoff's Articles

Will Soileau on Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal: These genetric companies are bottom dwelling, blood sucking... more »
jeff turner83 on Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal: Hey, AstraZeneca specialises in prescription medicines to fight... more »
quest on Court Dismisses Apotex's Cosopt Exclusivity Counterclaims Against Merck : This an interesting situation. So who gets the 180 days... more »

Latest Comments on Aaron F. Barkoff's Articles